Report #2847381

Received Jun 26, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: ND
Recovered: Unknown
Vaccinated: Jun 23, 2025
Onset: Jun 23, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	UNK	Z002626	—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

no patient symptoms have been reported; 1 dose of CAPVAXIVE involved in a temperature excursion was administered to a patient; This spontaneous report was received from a pharmacy intern (also reported as medical student) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-Jun-2025, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (lot #Z002626, expiration date: 04-Sep-2026, strength and route were unknown), 1 dosage form for prophylaxis (Product storage error). No patient symptoms have been reported (No adverse event). Administered dose of Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) experienced the temperature excursion below 15.8degree Celsius [C] for 8 Hours 0 Minutes 0 Seconds. No previous temperature excursions reported.